1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Lacosamide is redefining standards in neurology and pain management, driven by innovation in therapy personalization, digital health adoption, and evolving supply chain strategies. Senior industry leaders require a clear understanding of the market’s complexity, from granular segmentation to the strategic impact of regulatory shifts, to capture growth and mitigate risk effectively.
Market Snapshot: Lacosamide Market
In the past decade, lacosamide has established itself as a cornerstone antiepileptic and neuropathic pain therapy, supported by its unique mechanism, strong safety profile, and continued clinical expansion. The market is shaped by broader patient indications and differentiates itself with specialized formulations and advanced distribution networks to meet changing demands. The adoption of digital monitoring, value-based care models, and regionally tailored access approaches positions the market for sustainable growth and strategic transformation.
Scope & Segmentation
This analysis provides critical insight into how lacosamide is deployed across multiple dimensions, ensuring an actionable, up-to-date market view for decision-makers.
- Indication: Epilepsy (including generalized and partial-onset seizures) and neuropathic pain
- Formulation: Intravenous injection, oral solution, oral tablets
- Distribution Channel: Hospital, online (hybrid and pure), and retail pharmacies
- End User: Multi-specialty and neurology clinics, hospitals, homecare (assisted and self-administration)
- Dosage Strength: 50 mg, 100 mg, 150 mg, 200 mg
- Regions Covered: Americas, EMEA, Asia-Pacific, with nuanced coverage of strategic markets and major national sub-segments including United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina, United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland, China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
- Key Companies Examined: UCB S.A., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Cadila Healthcare Limited, Lupin Limited, Viatris Inc., Apotex Inc., Torrent Pharmaceuticals Ltd.
Key Takeaways & Strategic Insights
- The lacosamide market is shaped by significant advances in pharmacogenomic profiling, enabling clinicians to personalize seizure and pain management for refractory cases.
- Integration of artificial intelligence into dosing algorithms is enhancing therapeutic accuracy and patient tolerability, reducing trial-and-error in titration phases.
- Digital health and telepharmacy platforms have successfully expanded access, particularly to underserved geographies, while predictive analytics are optimizing inventory management and distribution resilience.
- Value-based contracting and real-world outcomes tracking are now core drivers of commercial strategy, aligning reimbursement to clinical benefit and improving patient engagement.
- Diverse formulation and dosage options allow for fine-tuned therapy regimens, with distinct advantages for acute interventions, pediatric and geriatric care, and chronic maintenance.
Tariff Impact: U.S. 2025 Adjustments
The United States’ revised 2025 tariff policies have added complexity and cost to the lacosamide supply chain by introducing higher input costs for key raw materials. Manufacturers are adapting by diversifying sourcing, negotiating long-term supplier contracts, and leveraging advanced customs and logistics technologies. Pricing teams are using real-world analytics and tiered frameworks to maintain access. These shifts are allowing the market to enhance both supply chain resilience and strategic agility despite higher regulatory hurdles.
Methodology & Data Sources
This report utilizes a mixed-methods approach, combining comprehensive secondary research from industry literature, regulatory filings, trial registries, and patents with expert interviews across neurology, regulatory strategy, and supply chain management. Data triangulation, peer reviews, and validation steps ensure high accuracy, consistency, and transparency.
Why This Report Matters
- Provides senior leaders with segment-specific intelligence for optimized decision-making in neurology and pain therapeutics.
- Delivers actionable recommendations to enhance patient engagement, supply chain robustness, and commercial innovation in the lacosamide domain.
- Equips stakeholders with the latest analysis of regulatory, competitive, and regional trends to inform high-impact strategic planning.
Conclusion
Lacosamide’s therapeutic evolution is anchored in technological progress and adaptive commercial strategy. Leaders prepared to align investments with these trends stand to achieve superior outcomes and competitive positioning across the neurology and pain management landscape.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of lacosamide off-label use in chronic neuropathic pain management
5.2. Entry of first lacosamide generics triggering competitive price erosion across major markets
5.3. Development of novel extended release lacosamide formulations improving patient compliance rates
5.4. Strategic alliances between innovator companies and local manufacturers to expand lacosamide distribution
5.5. Regulatory policy revisions accelerating approval timelines for intravenous lacosamide formulations
5.6. Rising investment in combination therapies pairing lacosamide with other antiepileptic drugs
5.7. Rapid growth in Asia Pacific lacosamide demand driven by expanding epilepsy diagnosis rates
5.2. Entry of first lacosamide generics triggering competitive price erosion across major markets
5.3. Development of novel extended release lacosamide formulations improving patient compliance rates
5.4. Strategic alliances between innovator companies and local manufacturers to expand lacosamide distribution
5.5. Regulatory policy revisions accelerating approval timelines for intravenous lacosamide formulations
5.6. Rising investment in combination therapies pairing lacosamide with other antiepileptic drugs
5.7. Rapid growth in Asia Pacific lacosamide demand driven by expanding epilepsy diagnosis rates
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Lacosamide Drugs Market, by Indication
8.1. Introduction
8.2. Epilepsy
8.2.1. Generalized Seizures
8.2.1.1. Absence Seizures
8.2.1.2. Tonic-Clonic Seizures
8.2.2. Partial Onset Seizures
8.2.2.1. Complex Partial Seizures
8.2.2.2. Simple Partial Seizures
8.3. Neuropathic Pain
8.2. Epilepsy
8.2.1. Generalized Seizures
8.2.1.1. Absence Seizures
8.2.1.2. Tonic-Clonic Seizures
8.2.2. Partial Onset Seizures
8.2.2.1. Complex Partial Seizures
8.2.2.2. Simple Partial Seizures
8.3. Neuropathic Pain
9. Lacosamide Drugs Market, by Formulation
9.1. Introduction
9.2. Intravenous Injection
9.3. Oral Solution
9.4. Oral Tablets
9.2. Intravenous Injection
9.3. Oral Solution
9.4. Oral Tablets
10. Lacosamide Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.3.1. Hybrid Online Pharmacies
10.3.2. Pure Online Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.3.1. Hybrid Online Pharmacies
10.3.2. Pure Online Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Lacosamide Drugs Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Multi-Specialty Clinics
11.2.2. Neurology Clinics
11.3. Homecare Settings
11.3.1. Assisted Administration
11.3.2. Self-Administration
11.4. Hospitals
11.2. Clinics
11.2.1. Multi-Specialty Clinics
11.2.2. Neurology Clinics
11.3. Homecare Settings
11.3.1. Assisted Administration
11.3.2. Self-Administration
11.4. Hospitals
12. Lacosamide Drugs Market, by Dosage Strength
12.1. Introduction
12.2. 100 mg
12.3. 150 mg
12.4. 200 mg
12.5. 50 mg
12.2. 100 mg
12.3. 150 mg
12.4. 200 mg
12.5. 50 mg
13. Americas Lacosamide Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Lacosamide Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Lacosamide Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. UCB S.A.
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Dr. Reddy’s Laboratories Ltd.
16.3.4. Sun Pharmaceutical Industries Ltd.
16.3.5. Hikma Pharmaceuticals PLC
16.3.6. Cadila Healthcare Limited
16.3.7. Lupin Limited
16.3.8. Viatris Inc.
16.3.9. Apotex Inc.
16.3.10. Torrent Pharmaceuticals Ltd.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. UCB S.A.
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Dr. Reddy’s Laboratories Ltd.
16.3.4. Sun Pharmaceutical Industries Ltd.
16.3.5. Hikma Pharmaceuticals PLC
16.3.6. Cadila Healthcare Limited
16.3.7. Lupin Limited
16.3.8. Viatris Inc.
16.3.9. Apotex Inc.
16.3.10. Torrent Pharmaceuticals Ltd.
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. LACOSAMIDE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LACOSAMIDE DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LACOSAMIDE DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. LACOSAMIDE DRUGS MARKET: RESEARCHAI
FIGURE 26. LACOSAMIDE DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. LACOSAMIDE DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. LACOSAMIDE DRUGS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LACOSAMIDE DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LACOSAMIDE DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. LACOSAMIDE DRUGS MARKET: RESEARCHAI
FIGURE 26. LACOSAMIDE DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. LACOSAMIDE DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. LACOSAMIDE DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LACOSAMIDE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ABSENCE SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ABSENCE SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY TONIC-CLONIC SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY TONIC-CLONIC SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COMPLEX PARTIAL SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COMPLEX PARTIAL SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY SIMPLE PARTIAL SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY SIMPLE PARTIAL SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ORAL TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HYBRID ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HYBRID ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PURE ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PURE ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 100 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 100 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 150 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 150 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 200 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 200 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 50 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 50 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 146. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 147. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 148. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 149. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 150. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 151. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 158. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 159. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 162. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 163. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 164. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 165. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 166. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 167. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 180. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 190. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 289. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 292. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 293. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 294. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 295. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 296. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 297. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 298. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 299. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 302. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 303. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 304. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 305. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 308. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 309. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 310. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 311. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 312. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 313. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 316. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 317. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 318. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 319. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 320. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 321. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 322. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 323. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 326. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 327. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 328. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 329. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 332. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 333. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 334. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 335. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 336. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (US
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ABSENCE SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ABSENCE SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY TONIC-CLONIC SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY TONIC-CLONIC SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COMPLEX PARTIAL SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY COMPLEX PARTIAL SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY SIMPLE PARTIAL SEIZURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY SIMPLE PARTIAL SEIZURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INTRAVENOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ORAL TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HYBRID ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HYBRID ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PURE ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY PURE ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 100 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 100 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 150 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 150 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 200 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 200 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 50 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LACOSAMIDE DRUGS MARKET SIZE, BY 50 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES LACOSAMIDE DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 146. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 147. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 148. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 149. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 150. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 151. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 158. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 159. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 162. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 163. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 164. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 165. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 166. CANADA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 167. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 170. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 171. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 180. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 190. MEXICO LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA LACOSAMIDE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 289. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 292. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 293. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 294. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 295. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 296. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 297. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 298. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 299. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 302. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 303. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 304. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 305. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 308. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 309. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 310. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 311. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 312. GERMANY LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 313. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 316. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 317. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 318. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (USD MILLION)
TABLE 319. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2018-2024 (USD MILLION)
TABLE 320. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY PARTIAL ONSET SEIZURES, 2025-2030 (USD MILLION)
TABLE 321. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 322. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 323. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 326. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 327. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 328. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 329. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 332. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 333. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 334. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY HOMECARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 335. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 336. FRANCE LACOSAMIDE DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY EPILEPSY, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA LACOSAMIDE DRUGS MARKET SIZE, BY GENERALIZED SEIZURES, 2025-2030 (US
Samples
LOADING...
Companies Mentioned
The companies profiled in this Lacosamide Drugs market report include:- UCB S.A.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy’s Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Cadila Healthcare Limited
- Lupin Limited
- Viatris Inc.
- Apotex Inc.
- Torrent Pharmaceuticals Ltd.
